Rubric Capital Management LP

Insider Reports History

Entity
Company
Location
155 East 44 Th St, Suite 1630, New York, NY
Signature
Rubric Capital Management LP, By: /s/ Michael Nachmani, its Chief Operating Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rubric Capital Management LP:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Talen Energy Corp 10%+ Owner Common Stock 6.12M $1.25B $204.35 Dec 13, 2024 Indirect
Radius Health, Inc. 10%+ Owner Common Stock, par value $0.0001 per share ("Common Stock") 8.64M $87M $10.07 Aug 11, 2022 Indirect
Mereo BioPharma Group plc 10%+ Owner American Depositary Shares ("ADSs") 15.3M $61.1M $3.99 Jun 17, 2024 Indirect
HERON THERAPEUTICS, INC. /DE/ 10%+ Owner Common Stock, par value $0.01 per share 26.7M $57.4M $2.15 Jul 21, 2023 Indirect
TherapeuticsMD, Inc. Director, Other*, 10%+ Owner Common Stock, par value $0.001 per share ("Common Stock") 2.95M $6.72M $2.28 Nov 15, 2023 Indirect
Mereo Biopharma Group plc 10%+ Owner Ordinary Shares, GBP 0.003 par value per share 32M Jan 1, 2024 Indirect
Vincerx Pharma, Inc. 10%+ Owner Common stock, par value $0.0001 per share 2.11M Jan 20, 2022 Indirect

Insider Reports Filed by Rubric Capital Management LP

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TLN Talen Energy Corp Dec 13, 2024 2 -$1B 4 Dec 16, 2024 10%+ Owner
TLN Talen Energy Corp Jul 9, 2024 0 $0 3 Jul 9, 2024 10%+ Owner
MREO Mereo BioPharma Group plc Jun 17, 2024 1 $7M 4 Jun 17, 2024 10%+ Owner
MREO Mereo Biopharma Group plc Jan 1, 2024 0 $0 3 Jan 2, 2024 10%+ Owner
TXMD TherapeuticsMD, Inc. Nov 15, 2023 1 $2M 4 Nov 17, 2023 Director, Other*, 10%+ Owner
HRTX HERON THERAPEUTICS, INC. /DE/ Jul 21, 2023 0 $0 3 Jul 25, 2023 10%+ Owner
TXMD TherapeuticsMD, Inc. Jun 28, 2023 1 $1.15M 4 Jun 29, 2023 Director, Other*, 10%+ Owner
HRTX HERON THERAPEUTICS, INC. /DE/ Jan 30, 2023 0 $0 3 Feb 8, 2023 Other*
TXMD TherapeuticsMD, Inc. Dec 30, 2022 1 -$38.7M 4/A Feb 22, 2023 Director, Other*, 10%+ Owner
TXMD TherapeuticsMD, Inc. Dec 9, 2022 1 $90.3K 4 Dec 12, 2022 10%+ Owner
TXMD TherapeuticsMD, Inc. Dec 7, 2022 2 $116K 4 Dec 9, 2022 10%+ Owner
TXMD TherapeuticsMD, Inc. Oct 28, 2022 1 $7M 4 Oct 31, 2022 10%+ Owner
TXMD TherapeuticsMD, Inc. Sep 30, 2022 1 $7M 4 Oct 3, 2022 10%+ Owner
RDUS Radius Health, Inc. Aug 10, 2022 1 $16.9M 4 Aug 12, 2022 10%+ Owner
RDUS Radius Health, Inc. Aug 10, 2022 1 $40.4K 4 Aug 11, 2022 10%+ Owner
TXMD TherapeuticsMD, Inc. Jul 29, 2022 2 $15M 4 Aug 1, 2022 10%+ Owner
TXMD TherapeuticsMD, Inc. Jul 15, 2022 2 $467K 4 Jul 19, 2022 10%+ Owner
TXMD TherapeuticsMD, Inc. Jul 14, 2022 0 $0 3 Jul 19, 2022 10%+ Owner
VINC Vincerx Pharma, Inc. Jan 20, 2022 0 $0 3 Jan 31, 2022 10%+ Owner
RDUS Radius Health, Inc. Dec 16, 2021 1 $1.04M 4 Dec 16, 2021 10%+ Owner
RDUS Radius Health, Inc. Dec 13, 2021 3 $3.19M 4 Dec 15, 2021 10%+ Owner
RDUS Radius Health, Inc. Dec 8, 2021 3 $12M 4 Dec 10, 2021 10%+ Owner
RDUS Radius Health, Inc. Dec 8, 2021 0 $0 3 Dec 10, 2021 10%+ Owner